vs
DENNY'S Corp（DENN）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
再鼎医药的季度营收约是DENNY'S Corp的1.1倍（$127.1M vs $113.2M），再鼎医药同比增速更快（17.1% vs 1.3%），DENNY'S Corp自由现金流更多（$16.0M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs -0.9%）
丹尼氏是源自美国的堂食美式连锁餐吧品牌，目前在全球多个国家和地区开展业务，仅在美国、加拿大、墨西哥、波多黎各等地就运营着超过1400家门店，主打轻松随性的美式正餐用餐体验。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
DENN vs ZLAB — 直观对比
营收规模更大
ZLAB
是对方的1.1倍
$113.2M
营收增速更快
ZLAB
高出15.8%
1.3%
自由现金流更多
DENN
多$42.6M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
-0.9%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $113.2M | $127.1M |
| 净利润 | $632.0K | — |
| 毛利率 | — | 51.0% |
| 营业利润率 | 9.2% | -54.6% |
| 净利率 | 0.6% | — |
| 营收同比 | 1.3% | 17.1% |
| 净利润同比 | -90.3% | — |
| 每股收益（稀释后） | $0.01 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DENNZLAB
| Q4 25 | — | $127.1M | ||
| Q3 25 | $113.2M | $115.4M | ||
| Q2 25 | $117.7M | $109.1M | ||
| Q1 25 | $111.6M | $105.7M | ||
| Q4 24 | $114.7M | $108.5M | ||
| Q3 24 | $111.8M | $101.8M | ||
| Q2 24 | $115.9M | $100.1M | ||
| Q1 24 | $110.0M | $87.1M |
净利润DENNZLAB
| Q4 25 | — | — | ||
| Q3 25 | $632.0K | $-36.0M | ||
| Q2 25 | $2.5M | $-40.7M | ||
| Q1 25 | $326.0K | $-48.4M | ||
| Q4 24 | $6.8M | — | ||
| Q3 24 | $6.5M | $-41.7M | ||
| Q2 24 | $3.6M | $-80.3M | ||
| Q1 24 | $4.7M | $-53.5M |
毛利率DENNZLAB
| Q4 25 | — | 51.0% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | — | 60.6% | ||
| Q1 25 | — | 63.6% | ||
| Q4 24 | — | 61.5% | ||
| Q3 24 | — | 64.1% | ||
| Q2 24 | — | 64.9% | ||
| Q1 24 | — | 61.4% |
营业利润率DENNZLAB
| Q4 25 | — | -54.6% | ||
| Q3 25 | 9.2% | -42.3% | ||
| Q2 25 | 7.3% | -50.3% | ||
| Q1 25 | 4.7% | -53.3% | ||
| Q4 24 | 12.6% | -62.6% | ||
| Q3 24 | 10.5% | -66.6% | ||
| Q2 24 | 7.9% | -76.0% | ||
| Q1 24 | 9.1% | -80.7% |
净利率DENNZLAB
| Q4 25 | — | — | ||
| Q3 25 | 0.6% | -31.2% | ||
| Q2 25 | 2.1% | -37.3% | ||
| Q1 25 | 0.3% | -45.8% | ||
| Q4 24 | 5.9% | — | ||
| Q3 24 | 5.8% | -40.9% | ||
| Q2 24 | 3.1% | -80.2% | ||
| Q1 24 | 4.3% | -61.4% |
每股收益（稀释后）DENNZLAB
| Q4 25 | — | $-0.05 | ||
| Q3 25 | $0.01 | $-0.03 | ||
| Q2 25 | $0.05 | $-0.04 | ||
| Q1 25 | $0.01 | $-0.04 | ||
| Q4 24 | $0.13 | $-0.09 | ||
| Q3 24 | $0.12 | $-0.04 | ||
| Q2 24 | $0.07 | $-0.08 | ||
| Q1 24 | $0.09 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-32.7M | $715.5M |
| 总资产 | $502.9M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DENNZLAB
| Q4 25 | — | $689.6M | ||
| Q3 25 | — | $717.2M | ||
| Q2 25 | — | $732.2M | ||
| Q1 25 | $1.1M | $757.3M | ||
| Q4 24 | $100.0K | $779.7M | ||
| Q3 24 | $2.9M | $616.1M | ||
| Q2 24 | $2.8M | $630.0M | ||
| Q1 24 | $2.8M | $650.8M |
总债务DENNZLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $270.6M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益DENNZLAB
| Q4 25 | — | $715.5M | ||
| Q3 25 | $-32.7M | $759.9M | ||
| Q2 25 | $-34.6M | $791.7M | ||
| Q1 25 | $-36.4M | $810.8M | ||
| Q4 24 | $-34.0M | $840.9M | ||
| Q3 24 | $-54.5M | $667.7M | ||
| Q2 24 | $-53.2M | $704.2M | ||
| Q1 24 | $-55.7M | $762.2M |
总资产DENNZLAB
| Q4 25 | — | $1.2B | ||
| Q3 25 | $502.9M | $1.2B | ||
| Q2 25 | $491.1M | $1.2B | ||
| Q1 25 | $488.1M | $1.2B | ||
| Q4 24 | $496.3M | $1.2B | ||
| Q3 24 | $461.6M | $985.3M | ||
| Q2 24 | $459.9M | $987.4M | ||
| Q1 24 | $460.4M | $988.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $16.0M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $16.0M | $-26.7M |
| 自由现金流率自由现金流/营收 | 14.1% | -21.0% |
| 资本支出强度资本支出/营收 | 0.0% | 0.5% |
| 现金转化率经营现金流/净利润 | 25.28× | — |
| 过去12个月自由现金流最近4个季度 | — | $-158.9M |
8季度趋势，按日历期对齐
经营现金流DENNZLAB
| Q4 25 | — | $-26.0M | ||
| Q3 25 | $16.0M | $-32.0M | ||
| Q2 25 | $9.4M | $-31.0M | ||
| Q1 25 | $5.0M | $-61.7M | ||
| Q4 24 | $8.5M | $-55.8M | ||
| Q3 24 | $6.6M | $-26.8M | ||
| Q2 24 | $14.2M | $-42.2M | ||
| Q1 24 | $215.0K | $-90.1M |
自由现金流DENNZLAB
| Q4 25 | — | $-26.7M | ||
| Q3 25 | $16.0M | $-35.0M | ||
| Q2 25 | — | $-33.9M | ||
| Q1 25 | — | $-63.2M | ||
| Q4 24 | — | $-58.4M | ||
| Q3 24 | — | $-28.2M | ||
| Q2 24 | — | $-42.9M | ||
| Q1 24 | — | $-91.1M |
自由现金流率DENNZLAB
| Q4 25 | — | -21.0% | ||
| Q3 25 | 14.1% | -30.4% | ||
| Q2 25 | — | -31.1% | ||
| Q1 25 | — | -59.9% | ||
| Q4 24 | — | -53.8% | ||
| Q3 24 | — | -27.7% | ||
| Q2 24 | — | -42.9% | ||
| Q1 24 | — | -104.5% |
资本支出强度DENNZLAB
| Q4 25 | — | 0.5% | ||
| Q3 25 | 0.0% | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 1.5% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | 0.0% | 1.3% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | — | 1.1% |
现金转化率DENNZLAB
| Q4 25 | — | — | ||
| Q3 25 | 25.28× | — | ||
| Q2 25 | 3.79× | — | ||
| Q1 25 | 15.38× | — | ||
| Q4 24 | 1.26× | — | ||
| Q3 24 | 1.01× | — | ||
| Q2 24 | 3.97× | — | ||
| Q1 24 | 0.05× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DENN
| Franchisor Owned Outlet | $57.4M | 51% |
| Royalty | $27.7M | 25% |
| Advertising | $18.6M | 16% |
| Occupancy | $7.7M | 7% |
| Initial And Other Fees | $1.7M | 1% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
